Medical News

With focus on the ethics and practices concerning women’s physical, mental and reproductive health; the upcoming FIGO Regional Conference of Middle East & Africa will raise many poignant issues. Having member societies in 130 countries, FIGO is the only non-profit organization in the world that brings together professional societies of obstetricians and gynecologists on a global basis and is dedicated to the improvement of women’s health and rights while reducing the disparities in healthcare available to women and newborns.

With Colorectal Cancer Awareness Month (March) now underway, experts at one of the region’s leading medical facilities is urging at risk groups to consider undergoing screening for the disease.

Zulekha Healthcare Group launched today its ‘Screen and Survive’ campaign in its third edition in the honourable presence of His Excellency Dr. Rashid Al Leem, Chairman of Sharjah Electricity & Water Authority. The campaign offers free screenings that are open to the public including residents and visitors from March 12th till April 30th 2018. The campaign aims to support the UAE’s national target of decreasing cancer fatalities by 18% by 2021.

Endometriosis is a painful disease that affects millions of women worldwide and quite a few in the Middle East too. It is estimated that 1 in 10 women is affected by endometriosis during reproductive years and approximately 30–50% of women with endometriosis will experience infertility. It is a condition in which tissue that normally grows inside the endometrial cavity grows outside it and can lead to severe pain during menstrual periods and chronic pain in the lower back and pelvis, often disabling. But that’s not all. It leads to infertility in a majority of cases. While a large part of the affected women are living with this medical condition – they only wake up to it when facing challenges in conception. It is then, that couples turn to IVF or reproductive medicine for treatment.

Igenomix, a company that provides advanced services in the field of reproductive genetics, has stressed on the importance of Carrier Genetic Testing (CGT) in the Middle East region. The screening procedure can help soon-to-be and newly-married couples in reducing the risk of passing on genetic diseases, which are caused by abnormalities present in the human DNA. In line with this, Igenomix is encouraging the use of CGT as an important pre-component in planning a family as it can help determine the risk of having a child with a genetic disorder. Upon the completion of the screening procedure, individuals will be able to know if they carry one or more recessive genetic mutation.